Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine (Q42906268)

10 November 2017

Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine (English)

1 reference

10 November 2017

1 reference

Koichi Hayashi

1

1 reference

10 November 2017

Takao Saruta

2

1 reference

10 November 2017

Yoshio Goto

3

1 reference

10 November 2017

Masao Ishii

4

1 reference

10 November 2017

JATOS Study Group

5

1 reference

10 November 2017

16 September 2010

1 reference

10 November 2017

Hypertension Research

1 reference

10 November 2017

33

1 reference

10 November 2017

11

1 reference

10 November 2017

1211-1220

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.162

10 November 2017

0 references

cites work

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Revised equations for estimated GFR from serum creatinine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Nongenomic vascular action of aldosterone in the glomerular microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Ca2+ channel subtypes and pharmacology in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Calcium antagonists: Do they equally protect against kidney injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Proteinuria and the risk of developing end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Extended prognostic value of urinary albumin excretion for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Kidney function and mortality among patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Rapid kidney function decline and mortality risk in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Disparate effects of calcium antagonists on renal microcirculation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.162

7 January 2021

Identifiers

DOI

10.1038/HR.2010.162

1 reference

Dimensions Publication ID

10 November 2017

0 references

1 reference